Blood News and Research

RSS

Genetic study reveals insights into ancestry-associated differences in type 2 diabetes

The development and progression of type 2 diabetes are affected by numerous biological processes, such as the body's response to insulin, the health of insulin-producing pancreatic beta cells, and the functioning of metabolic pathways.

6 Mar 2024

Study reveals link between blood amyloid levels and brain microstructure changes in Alzheimer's

New research published today suggests there is a link between abnormal blood levels of amyloid - a protein associated with Alzheimer's disease - and subtle changes in brain microstructures on a type of MRI, findings that could lead to a new way to detect Alzheimer's earlier in people with no clinical signs.

6 Mar 2024

NIH study reveals elevated cholesterol levels among American Indian youth

More than 70% of American Indian young adults aged 20-39 and 50% of American Indian teens have cholesterol levels or elevated fat in the blood that put them at risk for cardiovascular disease, suggests a study supported by the National Institutes of Health.

6 Mar 2024

New approach needed to better prepare and support women during menopause transition, experts say

A new approach to menopause that better prepares and supports women during midlife is needed – going beyond medical treatments, to empower women using high-quality information on symptoms and treatments, empathic clinical care and workplace adjustments as required, says a new four paper Series published in The Lancet.

6 Mar 2024

AvoMD partners with Mass General Brigham to develop inpatient emergency clinical care algorithms

Mass General Brigham, a leading integrated academic health care system, and the Healthcare Transformation Lab at Massachusetts General Hospital are proud to announce their collaboration with AvoMD, a digital clinical decision support platform that brings current medical evidence into the clinical workflow, to develop a series of inpatient emergency clinical care algorithms.

6 Mar 2024

ChatGPT outperforms Bing in providing information on home hypertension management

The responses given by the artificial intelligence tools ChatGPT and Bing to questions about blood pressure monitoring methods at home.

6 Mar 2024

Thinking of switching to Quorn? It could help lower bad cholesterol by 10%

A new Clinical Nutrition study investigated whether a home-based and remotely-delivered dietary intervention containing mycoprotein could influence cholesterol and other biomarkers of cardiovascular disease (CVD) in overweight adults.

6 Mar 2024

Even low levels of leisure-time physical activity can prevent stroke in the long term

Recently, scientists conducted a systematic review and metaanalysis to understand better whether different levels of leisure-time physical activity (LTPA) prevent stroke.

6 Mar 2024

The impact of sedentary behavior on the relationship between daily step counts and health outcomes

Researchers explore how sedentary time influences the relationship between daily step count and the risks of mortality and cardiovascular disease.

6 Mar 2024

Human molecular adaptations to fasting: Insights from proteomic analysis

Researchers investigate systemic proteome adaptations to one week of fasting in humans.

6 Mar 2024

Study shows link between sweetened drinks and higher atrial fibrillation risk

Adults who reported drinking two liters (about 67 ounces) or more of sugar- or artificially sweetened drinks per week had a higher risk of an irregular heart rhythm known as atrial fibrillation compared with adults who drank fewer such beverages, according to new research published today in Circulation: Arrhythmia and Electrophysiology, a peer-reviewed journal of the American Heart Association.

5 Mar 2024

Complicated pregnancies linked to two‐fold increased risk of later cardiovascular disease

Researchers from University of Bergen have investigated the relation between 40-year-old women's pregnancy history and later risk of dying of cardiovascular diseases.

5 Mar 2024

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver.

5 Mar 2024

New catheter-based device images heart disease plaques with unprecedented detail

Researchers have developed a new catheter-based device that combines two powerful optical techniques to image the dangerous plaques that can build up inside the arteries that supply blood to the heart.

5 Mar 2024

Researchers examine the immune response of a hypervaccinated individual

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen have examined a man who has received more than 200 vaccinations against Covid-19. They learned of his case via newspaper reports.

5 Mar 2024

Lack of sleep linked to higher risk of developing type 2 diabetes

Adults who sleep only three to five hours a day are at higher risk of developing type 2 diabetes. This is demonstrated in a new study from Uppsala University, published in JAMA Network Open.

5 Mar 2024

Robotic-assisted surgery for gallbladder cancer found to be as effective as traditional methods

Each year, approximately 2,000 people die annually of gallbladder cancer (GBC) in the U.S., with only one in five cases diagnosed at an early stage. With GBC rated as the first biliary tract cancer and the 17th most deadly cancer worldwide, pressing attention for proper management of disease must be addressed.

5 Mar 2024

DNA aptamer-based sensors can accurately detect trace amounts of fentanyl, heroin, and cocaine

Researchers from North Carolina State University have developed a new generation of high-performance DNA aptamers and highly accurate drug sensors for cocaine and other opioids.

5 Mar 2024

Navigating the complexities of controlled release drug formulations

This interview aims to address the challenges and complexities involved in the development and manufacturing of controlled release drug formulations.

From DSI, a PLG Company 5 Mar 2024

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

EXN407 is the first topical SRPK1 inhibitor to demonstrate both safety and signals of biological response as monotherapy for these indications.

5 Mar 2024

Blood News and Research

Genetic study reveals insights into ancestry-associated differences in type 2 diabetes

Study reveals link between blood amyloid levels and brain microstructure changes in Alzheimer's

NIH study reveals elevated cholesterol levels among American Indian youth

New approach needed to better prepare and support women during menopause transition, experts say

AvoMD partners with Mass General Brigham to develop inpatient emergency clinical care algorithms

ChatGPT outperforms Bing in providing information on home hypertension management

Thinking of switching to Quorn? It could help lower bad cholesterol by 10%

Even low levels of leisure-time physical activity can prevent stroke in the long term

The impact of sedentary behavior on the relationship between daily step counts and health outcomes

Human molecular adaptations to fasting: Insights from proteomic analysis

Study shows link between sweetened drinks and higher atrial fibrillation risk

Complicated pregnancies linked to two‐fold increased risk of later cardiovascular disease

Study shows semaglutide as a safe and effective therapy for MASLD in people with HIV

New catheter-based device images heart disease plaques with unprecedented detail

Researchers examine the immune response of a hypervaccinated individual

Lack of sleep linked to higher risk of developing type 2 diabetes

Robotic-assisted surgery for gallbladder cancer found to be as effective as traditional methods

DNA aptamer-based sensors can accurately detect trace amounts of fentanyl, heroin, and cocaine

Navigating the complexities of controlled release drug formulations

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News